Biblio

Export 1084 results:
Author Title [ Type(Desc)] Year
Filters: First Letter Of Last Name is T  [Clear All Filters]
Journal Article
E. C. K. Tan, Eriksdotter, M., Garcia-Ptacek, S., Fastbom, J., and Johnell, K., “Anticholinergic Burden and Risk of Stroke and Death in People with Different Types of Dementia.”, J Alzheimers Dis, vol. 65, no. 2, pp. 589-596, 2018.
A. Ivan B. Posis, Tarraf, W., Gonzalez, K. A., Soria-Lopez, J. A., Léger, G. C., Stickel, A. M., Daviglus, M. L., Lamar, M., Zeng, D., and González, H. M., “Anticholinergic Drug Burden and Neurocognitive Performance in the Study of Latinos-Investigation of Neurocognitive Aging.”, J Alzheimers Dis, vol. 86, no. 1, pp. 53-65, 2022.
P. Lampela, Tolppanen, A. - M., Tanskanen, A., Tiihonen, J., Hartikainen, S., and Taipale, H., “Anticholinergic Exposure and Risk of Pneumonia in Persons with Alzheimer's Disease: A Nested Case-Control Study.”, J Alzheimers Dis, vol. 56, no. 1, pp. 119-128, 2017.
P. Lampela, Tolppanen, A. - M., Tanskanen, A., Tiihonen, J., Hartikainen, S., and Taipale, H., “Anticholinergic Exposure and Risk of Pneumonia in Persons with Alzheimer's Disease: A Nested Case-Control Study.”, J Alzheimers Dis, vol. 56, no. 1, pp. 119-128, 2017.
P. Lampela, Tolppanen, A. - M., Tanskanen, A., Tiihonen, J., Hartikainen, S., and Taipale, H., “Anticholinergic Exposure and Risk of Pneumonia in Persons with Alzheimer's Disease: A Nested Case-Control Study.”, J Alzheimers Dis, vol. 56, no. 1, pp. 119-128, 2017.
P. Lampela, Tolppanen, A. - M., Tanskanen, A., Tiihonen, J., Hartikainen, S., and Taipale, H., “Anticholinergic Exposure and Risk of Pneumonia in Persons with Alzheimer's Disease: A Nested Case-Control Study.”, J Alzheimers Dis, vol. 56, no. 1, pp. 119-128, 2017.
H. Taipale, Lampela, P., Koponen, M., Tanskanen, A., Tiihonen, J., Hartikainen, S., and Tolppanen, A. - M., “Antiepileptic Drug Use Is Associated with an Increased Risk of Pneumonia Among Community-Dwelling Persons with Alzheimer's Disease-Matched Cohort Study.”, J Alzheimers Dis, vol. 68, no. 1, pp. 127-136, 2019.
H. Taipale, Lampela, P., Koponen, M., Tanskanen, A., Tiihonen, J., Hartikainen, S., and Tolppanen, A. - M., “Antiepileptic Drug Use Is Associated with an Increased Risk of Pneumonia Among Community-Dwelling Persons with Alzheimer's Disease-Matched Cohort Study.”, J Alzheimers Dis, vol. 68, no. 1, pp. 127-136, 2019.
H. Taipale, Lampela, P., Koponen, M., Tanskanen, A., Tiihonen, J., Hartikainen, S., and Tolppanen, A. - M., “Antiepileptic Drug Use Is Associated with an Increased Risk of Pneumonia Among Community-Dwelling Persons with Alzheimer's Disease-Matched Cohort Study.”, J Alzheimers Dis, vol. 68, no. 1, pp. 127-136, 2019.
H. Taipale, Lampela, P., Koponen, M., Tanskanen, A., Tiihonen, J., Hartikainen, S., and Tolppanen, A. - M., “Antiepileptic Drug Use Is Associated with an Increased Risk of Pneumonia Among Community-Dwelling Persons with Alzheimer's Disease-Matched Cohort Study.”, J Alzheimers Dis, vol. 68, no. 1, pp. 127-136, 2019.
J. D. Edwards, Ramirez, J., Callahan, B. L., Tobe, S. W., Oh, P., Berezuk, C., Lanctôt, K., Swardfager, W., Nestor, S., Kiss, A., Strother, S., and Black, S. E., “Antihypertensive Treatment is associated with MRI-Derived Markers of Neurodegeneration and Impaired Cognition: A Propensity-Weighted Cohort Study.”, J Alzheimers Dis, vol. 59, no. 3, pp. 1113-1122, 2017.
M. Stravalaci, Tapella, L., Beeg, M., Rossi, A., Joshi, P., Pizzi, E., Mazzanti, M., Balducci, C., Forloni, G., Biasini, E., Salmona, M., Diomede, L., Chiesa, R., and Gobbi, M., “The Anti-Prion Antibody 15B3 Detects Toxic Amyloid-β Oligomers.”, J Alzheimers Dis, vol. 53, no. 4, pp. 1485-97, 2016.
M. Vandermeeren, Borgers, M., Van Kolen, K., Theunis, C., Vasconcelos, B., Bottelbergs, A., Wintmolders, C., Daneels, G., Willems, R., Dockx, K., Delbroek, L., Marreiro, A., Donck, L. Ver, Sousa, C., Nanjunda, R., Lacy, E., Van De Casteele, T., Van Dam, D., De Deyn, P. Paul, Kemp, J. A., Malia, T. J., and Mercken, M. H., “Anti-Tau Monoclonal Antibodies Derived from Soluble and Filamentous Tau Show Diverse Functional Properties in vitro and in vivo.”, J Alzheimers Dis, vol. 65, no. 1, pp. 265-281, 2018.
H. Salem, Suchting, R., Gonzales, M. M., Seshadri, S., and Teixeira, A. L., “Apathy as a Predictor of Conversion from Mild Cognitive Impairment to Alzheimer's Disease: A Texas Alzheimer's Research and Care Consortium (TARCC) Cohort-Based Analysis.”, J Alzheimers Dis, vol. 92, no. 1, pp. 129-139, 2023.
E. Del Valle, Navarro, A., Martínez-Pinilla, E., Torices, S., and Tolivia, J., “Apo J and Apo D: Complementary or Antagonistic Roles in Alzheimer's Disease?”, J Alzheimers Dis, vol. 53, no. 2, pp. 639-50, 2016.
E. Del Valle, Navarro, A., Martínez-Pinilla, E., Torices, S., and Tolivia, J., “Apo J and Apo D: Complementary or Antagonistic Roles in Alzheimer's Disease?”, J Alzheimers Dis, vol. 53, no. 2, pp. 639-50, 2016.
X. Tang, Holland, D., Dale, A. M., and Miller, M. I., “APOE Affects the Volume and Shape of the Amygdala and the Hippocampus in Mild Cognitive Impairment and Alzheimer's Disease: Age Matters.”, J Alzheimers Dis, vol. 47, no. 3, pp. 645-60, 2015.
J. B. Toledo, Habes, M., Sotiras, A., Bjerke, M., Fan, Y., Weiner, M. W., Shaw, L. M., Davatzikos, C., and Trojanowski, J. Q., “APOE Effect on Amyloid-β PET Spatial Distribution, Deposition Rate, and Cut-Points.”, J Alzheimers Dis, vol. 69, no. 3, pp. 783-793, 2019.
J. B. Toledo, Habes, M., Sotiras, A., Bjerke, M., Fan, Y., Weiner, M. W., Shaw, L. M., Davatzikos, C., and Trojanowski, J. Q., “APOE Effect on Amyloid-β PET Spatial Distribution, Deposition Rate, and Cut-Points.”, J Alzheimers Dis, vol. 69, no. 3, pp. 783-793, 2019.
J. Foraker, Millard, S. P., Leong, L., Thomson, Z., Chen, S., C Keene, D., Bekris, L. M., and Yu, C. - E., “The APOE Gene is Differentially Methylated in Alzheimer's Disease.”, J Alzheimers Dis, 2015.
M. Berger, Cooter, M., Roesler, A. S., Chung, S., Park, J., Modliszewski, J. L., VanDusen, K. W., J Thompson, W., Moseley, A., Devinney, M. J., Smani, S., Hall, A., Cai, V., Browndyke, J. N., Lutz, M. W., and Corcoran, D. L., “APOE4 Copy Number-Dependent Proteomic Changes in the Cerebrospinal Fluid.”, J Alzheimers Dis, vol. 79, no. 2, pp. 511-530, 2021.
R. E. R. Slot, Van Harten, A. C., Kester, M. I., Jongbloed, W., Bouwman, F. H., Teunissen, C. E., Scheltens, P., Veerhuis, R., and van der Flier, W. M., “Apolipoprotein A1 in Cerebrospinal Fluid and Plasma and Progression to Alzheimer's Disease in Non-Demented Elderly.”, J Alzheimers Dis, vol. 56, no. 2, pp. 687-697, 2017.
F. Sellal, Wallon, D., Martinez-Almoyna, L., Marelli, C., Dhar, A., Oesterlé, H., Rovelet-Lecrux, A., Rousseau, S., Kourkoulis, C. E., Rosand, J., DiPucchio, Z. Y., Frosch, M., Gombert, C., Audoin, B., Miné, M., Riant, F., Frebourg, T., Hannequin, D., Campion, D., Greenberg, S. M., Tournier-Lasserve, E., and Nicolas, G., “APP Mutations in Cerebral Amyloid Angiopathy with or without Cortical Calcifications: Report of Three Families and a Literature Review.”, J Alzheimers Dis, vol. 56, no. 1, pp. 37-46, 2017.
H. - F. Wang, Tan, L., Cao, L., Zhu, X. - C., Jiang, T., Tan, M. - S., Liu, Y., Wang, C., Tsai, R. M., Jia, J. - P., and Yu, J. - T., “Application of the IWG-2 Diagnostic Criteria for Alzheimer's Disease to the ADNI.”, J Alzheimers Dis, vol. 51, no. 1, pp. 227-36, 2016.
H. - F. Wang, Tan, L., Cao, L., Zhu, X. - C., Jiang, T., Tan, M. - S., Liu, Y., Wang, C., Tsai, R. M., Jia, J. - P., and Yu, J. - T., “Application of the IWG-2 Diagnostic Criteria for Alzheimer's Disease to the ADNI.”, J Alzheimers Dis, vol. 51, no. 1, pp. 227-36, 2016.

Pages